Market Opportunity:
The AI healthcare market is rapidly growing, with a projected value of $148.4 billion by 2029, growing at a compound annual growth rate (CAGR) of 48.1% from 2024 to 2029 (Markets and Markets1). PharmBot AI is positioned to capture a significant share of this market with its innovative solutions.
ROI Potential:
Investing in PharmBot AI offers high return potential. Our financial projections show steady revenue growth, with an expected ROI of 35% over the next five years. Previous campaigns have generated significant interest, demonstrating our market viability.
Competitive Advantage:
PharmBot AI stands out due to its advanced AI algorithms, personalised medication management, and seamless integration with existing pharmacy systems. Our platform’s unique capabilities provide a competitive edge in the market.
Financial Projections:
Year 1:
Revenue: £500,000
Operating Expenses: £300,000
Net Profit: £200,000
Year 2:
Revenue: £1,200,000
Operating Expenses: £700,000
Net Profit: £500,000
Year 3:
Revenue: £2,500,000
Operating Expenses: £1,200,000
Net Profit: £1,300,000
Year 4:
Revenue: £4,000,000
Operating Expenses: £2,000,000
Net Profit: £2,000,000
Year 5:
Revenue: £7,000,000
Operating Expenses: £3,500,000
Net Profit: £3,500,000
Traction and Milestones:
Initial Stage: We are in the initial stage of development, focusing on building a robust platform and securing early adopters.
Upcoming Milestones: Planning pilot studies and partnerships with leading pharmacies and healthcare providers.
Team Expertise:
Our founding team consists of industry veterans with extensive experience in AI and healthcare. Our advisors include renowned experts who provide strategic guidance and insights.
Get in Touch:
Interested in learning more? Contact us to discuss investment opportunities, schedule a meeting, or download our detailed investment prospectus.
